BA.3.2, a closely mutated new COVID-19 variant which can be higher in a position to escape immunity from vaccines or prior an infection, is now spreading in the USA.
Though COVID instances are at the moment low nationally, the BA.3.2 pressure is gaining traction throughout the globe. BA.3.2, aka “cicada,” emerged over a 12 months in the past and slowly simmered till final fall, when it began ramping up in a number of nations, together with the U.S.
As of February, BA.3.2 has been detected in a minimum of 25 states, the U.S. Facilities for Illness Management and Prevention mentioned.
Maybe extra regarding is the variant’s slew of genetic modifications in its spike protein, which set it other than different variants circulating, Andrew Pekosz, Ph.D., a virologist on the Johns Hopkins Bloomberg College of Public Well being, tells TODAY.com.
“It has a number of mutations which will trigger it to look completely different to your immune system,” Pekosz says.
These have the potential to scale back safety from a previous COVID an infection or vaccination, based on a brand new research printed within the CDC’s newest Morbidity and Mortality Weekly Report.
Consequently, the “hyper-mutated” pressure is being carefully tracked by public well being officers. In December 2025, the World Well being Group labeled BA.3.2 as a “variant underneath monitoring.”
BA.3.2 was nicknamed “cicada” by T. Ryan Gregory, Ph.D., a professor of evolutionary biology on the College of Guelph who’s coined different variant names like “stratus” and “pirola.”
Like its namesake insect, BA.3.2 additionally spent its first years “underground” earlier than re-emerging as a possible main variant, Gregory tells TODAY.com.
Here is what to learn about BA.3.2, the place it is spreading, potential signs and the effectiveness of vaccines in opposition to it.
What Is the New COVID Variant, BA.3.2?
BA.3.2 was first recognized in November 2024 in South Africa. It is a descendent of BA.3, an omicron subvariant that emerged in 2022 and briefly circulated with BA.1 and BA.2, the CDC mentioned.
Its ancestor BA.3 fizzled out, however by no means disappeared, says Pekosz. Two years and dozens of mutations later, BA.3.2 emerged.
Since 2024, BA.3.2 has moved slowly and quietly, overshadowed by dominant variants like Nimbus and XFG — which all descend from BA.2. Final September, BA.3.2 began taking off.
“It was underneath the radar, replicating, till it began to unfold extra from individual to individual,” says Pekosz.
BA.3.2 has 75 mutations in its spike protein — that is loads, says Pekosz — which set it other than JN.1 and LP.8.1, the strains focused by present COVID-19 vaccines.
In response to the CDC, BA.3.2 represents a brand new lineage that is “genetically distinct” from the household of variants we have seen lately. “We predict it’d be capable to evade a number of the immunity already within the inhabitants,” says Pekosz.
In laboratory research, BA.3.2 successfully escaped COVID-19 antibodies as a consequence of its spike protein modifications, the CDC mentioned.
“What’s attention-grabbing, nonetheless, is a few of these mutations may very well make the virus bind much less effectively to our cells. So sure, our immune system might not acknowledge it, nevertheless it additionally does not acknowledge us as effectively,” Dr. Dana Mazo, an infectious illnesses doctor at NYU Langone Well being, tells TODAY.com.
Why is BA.3.2 resurfacing now? That is unclear, Mazo says.
Does the New COVID Variant Trigger Extra Extreme Sickness?
Is BA.3.2 making individuals sicker?
“There is not any proof that BA.3.2 is inflicting extra extreme illness or hospitalizations in nations the place it is extra widespread,” Dr. Adolfo García-Sastre, director of the worldwide well being and rising pathogens institute at Mt. Sinai, tells TODAY.com.
Pekosz provides: “It appears to be like scary on paper, nevertheless it hasn’t actually made a huge impact when it comes to illness in most locations but.”
The place Is BA.3.2 Spreading?
As of Feb. 11, 2026, BA.3.2 has unfold to a minimum of 23 nations, per information from the CDC and the World Initiative on Sharing All Influenza Knowledge (GISAID) database. It is driving about 30% of instances in Denmark, Germany and the Netherlands, per the CDC.
BA.3.2 was first detected within the U.S. in June 2025 in a traveler coming back from the Netherlands on the San Francisco Worldwide Airport, the CDC mentioned. Since then, it has been detected in worldwide vacationers, COVID sufferers and wastewater samples.
BA.3.2 is spreading in a minimum of 25 states, per the CDC:
- California
- Connecticut
- Florida
- Hawaii
- Idaho
- Louisiana
- Maine
- Maryland
- Massachusetts
- Michigan
- Missouri
- Nevada
- New Hampshire
- New Jersey
- New York
- Ohio
- Pennsylvania
- Rhode Island
- South Carolina
- Texas
- Utah
- Vermont
- Virginia
- Wyoming
At the moment, BA.3.2 is just not fueling sufficient instances to be added to the CDC’s variant proportion tracker.
Nonetheless, the newest information from WastewaterSCAN, a Stanford College-run program that tracks illnesses, present BA.3.2 has been detected in 3.7% of sewage samples nationwide, a spokesperson tells TODAY.com.
“There are nonetheless a number of unknown questions on how prevalent it’s within the U.S., as a result of surveillance has been lowered loads,” García-Sastre says.
Will BA.3.2 Trigger a Surge within the U.S.?
Though BA.3.2 detections are going up, it is nonetheless circulating at a comparatively low stage in lots of nations, together with the U.S. “It is growing, nevertheless it hasn’t actually prompted an enormous surge of infections anyplace,” Pekosz provides.
Cicada hasn’t overtaken the present dominant variants, XFG (stratus), NB.1.8.1 (nimbus) and their descendants, Gregory provides.
“BA.3.2 has not proven a sustained progress benefit over different every other co-circulating variant,” the WHO mentioned.
“If it had actually particular benefits, we might in all probability have seen it take off and dominate globally comparatively rapidly. We did not see that, nevertheless it’s not going away, so it is one thing to control,” says Pekosz.
Even when BA.3.2 can evade present immunity, there’ll seemingly nonetheless be some “cross-reactivity,” so it will not be an entire stranger to our immune methods, the specialists say.
COVID-19 will be unpredictable, so solely time will inform. “It might evolve to be bit higher at spreading or inflicting illness, however we simply do not know,” says Pekosz.
Nonetheless, it is unlikely that BA.3.2 will trigger a wave as giant or extreme as those seen very early within the pandemic, he provides.
Signs of the New COVID Variant BA.3.2
The signs of BA.3.2 are just like these brought on by different current variants, the specialists word.
In response to the CDC, frequent COVID-19 signs in 2026 embrace:
- Cough
- Fever or chills
- Sore throat
- Congestion
- Shortness of breath
- Lack of odor or style
- Fatigue
- Headache
- Gastrointestinal signs
Signs can differ relying on the individual, however often go away on their very own with supportive care.
“The brand new variant continues to be delicate to COVID antiviral medication that we’ve got been growing, so a minimum of these will work,” says García-Sastre.
Do Vaccines Shield Towards the New COVID Variant?
BA.3.2 has drawn consideration partly as a result of the modifications in its spike protein have might have an effect on how effectively the vaccine protects in opposition to an infection, highlighting the necessity for doable reformulation, the specialists word.
The 2025-2026 COVID vaccines, which goal the JN.1 lineage, are efficient at defending in opposition to extreme illness from present strains.
In lab research, these vaccines have been much less efficient in opposition to BA.3.2, however extra analysis is required, the CDC mentioned.
“It isn’t fully clear how efficient the present vaccine might be, nevertheless it seemingly nonetheless has some effectiveness,” García-Sastre says.
In response to the WHO, present COVID vaccines “are anticipated to proceed offering safety in opposition to extreme illness.”
Vaccines are usually reformulated in the summertime and might shield in opposition to a number of strains. “One fantastic thing about this vaccine is that we will replace it yearly,” says Mazo.
Within the meantime, you may nonetheless shield your self and others by testing when you’ve got signs, staying house when sick and carrying a masks in high-risk (crowded, indoor) settings.
If you have not been vaccinated or contaminated with COVID within the final six to 12 months, it might be price speaking to your physician about whether or not a booster is best for you, says García-Sastre.
Vaccination is especially vital for individuals at increased danger of extreme illness from COVID-19, which embrace adults over 65 and people with weakened immune methods or underlying situations.
“Vaccination continues to be going to assist restrict instances,” says Pekosz.
